Protocol Ledger

NCT04668157 · Phase III · COMPLETED

A Study of TAK-536 in Children From 2 to Less Than 6 Years Old With High Blood Pressure

Interventional Phase III clinical trial protocol NCT04668157 sponsored by Takeda in Cardiovascular and Thrombosis, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2021-05-17 Enrollment: 10 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT04668157
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)10 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)1 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT04668157
Protocol FieldVerified Registry Value
NCT IdentifierNCT04668157
Consolidated Lead SponsorTakeda
Therapeutic Condition CohortCardiovascular and Thrombosis
Clinical Trial PhasePhase III
Overall Recruitment StatusCOMPLETED
Registered Enrollment10 participants (ACTUAL)
Registered Start Date2021-05-17
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT04668157
Hospital Research SiteLocationSite Profile
Tohoku University HospitalSendai, JapanOpen Hospital Dossier ->

Related Filings Across Meru Platforms

Verified cross-ledger federal filings for Takeda across sibling Meru public-data platforms.

Search related sites and sponsors in the Interactive Directory, explore Cardiovascular and Thrombosis Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI